INTELLIGENT BIO SOLUTIONS INC. Payments of Stock Issuance Costs
INTELLIGENT BIO SOLUTIONS INC. (INBS) reported Payments of Stock Issuance Costs of $20.63 thousand for the 6-month period ending 2024-12-31, per its 10-Q filed 2025-02-13.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2025-02-13
- INTELLIGENT BIO SOLUTIONS INC. payments of stock issuance costs for the quarter ending 2023-06-30 was $54.19K.
- INTELLIGENT BIO SOLUTIONS INC. payments of stock issuance costs for the quarter ending 2023-03-31 was -$35.09K.
- INTELLIGENT BIO SOLUTIONS INC. payments of stock issuance costs for the quarter ending 2021-06-30 was $0.00.
- INTELLIGENT BIO SOLUTIONS INC. payments of stock issuance costs for the quarter ending 2021-03-31 was $0.00.
- INTELLIGENT BIO SOLUTIONS INC. payments of stock issuance costs for fiscal 2023 was $518.91K.
- INTELLIGENT BIO SOLUTIONS INC. payments of stock issuance costs for fiscal 2021 was $2.00M.
| Period end | Payments of Stock Issuance Costs 3 month | Payments of Stock Issuance Costs 6 month | Payments of Stock Issuance Costs 9 month | Payments of Stock Issuance Costs 12 month |
|---|---|---|---|---|
| 2024-12-31 | $20.63K 10-Q · filed 2025-02-13 | |||
| 2023-12-31 | $592.36K 10-Q · filed 2025-02-13 | |||
| 2023-06-30 | $54.19K derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-18 | $19.10K derived: sum of 2 quarters · filed 2024-09-18 | $518.91K 10-K · filed 2024-09-18 | |
| 2023-03-31 | -$35.09K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-08 | $464.73K 10-Q · filed 2024-05-08 | ||
| 2022-12-31 | $499.82K 10-Q · filed 2024-02-09 | |||
| 2021-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-22 | $0.00 derived: sum of 2 quarters · filed 2022-09-22 | $2.00M 10-K · filed 2022-09-22 | |
| 2021-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-05-16 | $2.00M 10-Q · filed 2022-05-16 | ||
| 2020-12-31 | $2.00M 10-Q · filed 2022-02-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |